|
1
|
Neilson EG: Mechanisms of disease:
fibroblasts - a new look at an old problem. Nat Clin Pract Nephrol.
2:101–108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wynn TA: Cellular and molecular mechanisms
of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar
|
|
3
|
Liu Y: Epithelial to mesenchymal
transition in renal fibrogenesis: pathologic significance,
molecular mechanism, and therapeutic intervention. J Am Soc
Nephrol. 15:1–12. 2004. View Article : Google Scholar
|
|
4
|
Miyajima A, Chen J, Lawrence C, et al:
Antibody to transforming growth factor-beta ameliorates tubular
apoptosis in unilateral ureteral obstruction. Kidney Int.
58:2301–2313. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grande MT and López-Novoa JM: Fibroblast
activation and myofibroblast generation in obstructive nephropathy.
Nat Rev Nephrol. 5:319–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuratsune M, Masaki T, Hirai T, et al:
Signal transducer and activator of transcription 3 involvement in
the development of renal interstitial fibrosis after unilateral
ureteral obstruction. Nephrology (Carlton). 12:565–571. 2007.
View Article : Google Scholar
|
|
7
|
Arany I, Megyesi JK, Nelkin BD and
Safirstein RL: STAT3 attenuates EGFR-mediated ERK activation and
cell survival during oxidant stress in mouse proximal tubular
cells. Kidney Int. 70:669–674. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang N, Luo M, Li R, et al: Blockage of
JAK/STAT signalling attenuates renal ischaemia-reperfusion injury
in rat. Nephrol Dial Transplant. 23:91–100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stepkowski SM, Chen W, Ross JA, et al:
STAT3: an important regulator of multiple cytokine functions.
Transplantation. 85:1372–1377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Turkson J and Jove R: STAT proteins: novel
molecular targets for cancer drug discovery. Oncogene.
19:6613–6626. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yeh CH, Chiang HS, Lai TY and Chien CT:
Unilateral ureteral obstruction evokes renal tubular apoptosis via
the enhanced oxidative stress and endoplasmic reticulum stress in
the rat. Neurourol Urodyn. 30:472–479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jones EA, Shahed A and Shoskes DA:
Modulation of apoptotic and inflammatory genes by bioflavonoids and
angiotensin II inhibition in ureteral obstruction. Urology.
56:346–351. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Coleman CM, Minor JJ, Burt LE, et al:
Angiotensin AT1-receptor inhibition exacerbates renal injury
resulting from partial unilateral ureteral obstruction in the
neonatal rat. Am J Physiol Renal Physiol. 293:F262–F268. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishidoya S, Morrissey J, McCracken R, et
al: Angiotensin II receptor antagonist ameliorates renal
tubulointerstitial fibrosis caused by unilateral ureteral
obstruction. Kidney Int. 47:1285–1294. 1995. View Article : Google Scholar
|
|
15
|
Radović N, Cuzić S and Knotek M: Effect of
unilateral ureteral obstruction and anti-angiotensin II treatment
on renal tubule and interstitial cell apoptosis in rats. Croat Med
J. 49:600–607. 2008.
|
|
16
|
Otsuka F, Yamauchi T, Kataoka H, et al:
Effects of chronic inhibition of ACE and AT1 receptors on
glomerular injury in dahl salt-sensitive rats. Am J Physiol.
274:R1797–R1806. 1998.PubMed/NCBI
|
|
17
|
Fujihara CK, Velho M, Malheiros DM and
Zatz R: An extremely high dose of losartan affords superior
renoprotection in the remnant model. Kidney Int. 67:1913–1924.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Manucha W, Oliveros L, Carrizo L, et al:
Losartan modulation on NOS isoforms and COX-2 expression in early
renal fibrogenesis in unilateral obstruction. Kidney Int.
65:2091–2107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kellner D, Chen J, Richardson I, et al:
Angiotensin receptor blockade decreases fibrosis and fibroblast
expression in a rat model of unilateral ureteral obstruction. J
Urol. 176:806–812. 2006. View Article : Google Scholar
|
|
20
|
Eskild-Jensen A, Paulsen LF, Wogensen L,
et al: AT1 receptor blockade prevents interstitial and glomerular
apoptosis but not fibrosis in pigs with neonatal induced partial
unilateral ureteral obstruction. Am J Physiol Renal Physiol.
292:F1771–F1781. 2007. View Article : Google Scholar
|
|
21
|
Roxburgh SA, Murphy M, Pollock CA and
Brazil DP: Recapitulation of embryological programmes in renal
fibrosis - the importance of epithelial cell plasticity and
developmental genes. Nephron Physiol. 103:p139–p148. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chuang PY and He JC: JAK/STAT signaling in
renal diseases. Kidney Int. 78:231–234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pang M, Ma L, Gong R, et al: A novel STAT3
inhibitor, S3I-201, attenuates renal interstitial fibroblast
activation and interstitial fibrosis in obstructive nephropathy.
Kidney Int. 78:257–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsuda H, Mori T, Kurumazuka D, et al:
Inhibitory effects of T/L-type calcium channel blockers on
tubulointerstitial fibrosis in obstructed kidneys in rats. Urology.
77:249.e9–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pang M, Kothapally J, Mao H, et al:
Inhibition of histone deacetylase activity attenuates renal
fibroblast activation and interstitial fibrosis in obstructive
nephropathy. Am J Physiol Renal Physiol. 297:F996–F1005. 2009.
View Article : Google Scholar
|
|
26
|
Yang J, Dai C and Liu Y: Hepatocyte growth
factor gene therapy and angiotensin II blockade synergistically
attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol.
13:2464–2477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu N, Tolbert E, Ponnusamy M, et al:
Delayed administration of suramin attenuates the progression of
renal fibrosis in obstructive nephropathy. J Pharmacol Exp Ther.
338:758–766. 2011. View Article : Google Scholar : PubMed/NCBI
|
